close 73% de los inversores minoristas pierde dinero cuando opera CFDs con este proveedor. Invertir conlleva riesgos y no es adecuado para todos los inversores. Los CFDs son instrumentos complejos y conllevan un alto riesgo de perder dinero rápidamente debido al apalancamiento. 73% de inversores minoristas pierde dinero al operar CFDs con este proveedor. Debes considerar si entiendes cómo funcionan los CFDs y si puedes permitirte asumir el alto riesgo de perder tu dinero.
BuscarBuscar
Change languageEspañol
Dashboard

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

Inicio・Lista de Acciones・VIRIDIAN THERAPEUTICS INC
Search

VIRIDIAN THERAPEUTICS INC

Cerrado

SectorSanidad

30.3 3.13

Compra Fuerte

Precios actualizados 21 nov 2025, 20:59 UTC

ComprarVender

Resumen

Variación precio

24h

Actual

Mínimo

28.77

Máximo

30.73

Métricas clave

By Trading Economics

Ingresos

66M

-35M

Ventas

70M

71M

Margen de beneficios

-49.028

Empleados

143

EBITDA

66M

-34M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+34.82% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

613M

2.8B

Apertura anterior

27.17

Cierre anterior

30.3

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

182 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

12 / 13.14 Soporte y Resistencia

VIRIDIAN THERAPEUTICS INC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

21 nov 2025, 22:42 UTC

Charlas de Mercado

Fitch Raises Cyprus's Outlook to Positive From Stable -- Market Talk

DJ

Leer

21 nov 2025, 21:50 UTC

Charlas de Mercado
Ganancias

Tech, Media & Telecom Roundup: Market Talk

DJ

Leer

21 nov 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

DJ

Leer

21 nov 2025, 21:47 UTC

Charlas de Mercado

Mexico's 3Q GDP Prompts Growth Downgrades -- Market Talk

DJ

Leer

21 nov 2025, 21:43 UTC

Charlas de Mercado

U.S. Crude Production Defies Low Prices, Rig Count -- Market Talk

DJ

Leer

21 nov 2025, 20:18 UTC

Charlas de Mercado

Oil Futures Fall on U.S. Push for Russia-Ukraine Peace -- Market Talk

DJ

Leer

21 nov 2025, 20:14 UTC

Charlas de Mercado

U.S. Natural Gas Gains As Traders Focus on Weather -- Market Talk

DJ

Leer

21 nov 2025, 19:48 UTC

Charlas de Mercado

Precious Metals Fall for the Week -- Market Talk

DJ

Leer

21 nov 2025, 19:44 UTC

Ganancias

Deere Earnings, Inflation Data, Black Friday: What to Watch in the Next Week -- WSJ

DJ

Leer

21 nov 2025, 19:37 UTC

Charlas de Mercado

Dollar Stalls as Stocks and Bonds Rise -- Market Talk

DJ

Leer

21 nov 2025, 19:27 UTC

Charlas de Mercado
Ganancias

Global Equities Roundup: Market Talk

DJ

Leer

21 nov 2025, 19:27 UTC

Charlas de Mercado
Ganancias

Intuit Seen With Underappreciated Credit Karma Momentum -- Market Talk

DJ

Leer

21 nov 2025, 19:20 UTC

Charlas de Mercado

European Natural Gas Premium Versus U.S. Shrinks -- Market Talk

DJ

Leer

21 nov 2025, 18:44 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Palo Alto-Chronosphere Synergies Questioned Despite M&A Record -- Market Talk

DJ

Leer

21 nov 2025, 18:37 UTC

Charlas de Mercado

U.S. Oil Rig Count Rises By 2 to 419 -- Market Talk

DJ

Leer

21 nov 2025, 18:34 UTC

Charlas de Mercado
Ganancias

Intuit Seen Outperforming on Conservative Guidance -- Market Talk

DJ

Leer

21 nov 2025, 18:28 UTC

Ganancias

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

DJ

Leer

21 nov 2025, 18:03 UTC

Charlas de Mercado

Mexico's Inflation Seen Up Slightly in Early November -- Market Talk

DJ

Leer

21 nov 2025, 17:24 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

DJ

Leer

21 nov 2025, 17:24 UTC

Charlas de Mercado

Intuit Seen on Path to Increase Growth -- Market Talk

DJ

Leer

21 nov 2025, 17:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

DJ

Leer

21 nov 2025, 17:05 UTC

Charlas de Mercado

Lowe's Getting Boost From Busy Small to Medium Pro Customer -- Market Talk

DJ

Leer

21 nov 2025, 16:56 UTC

Charlas de Mercado

Gold Recovers as Investors Boost Rate-Cut Bets -- Market Talk

DJ

Leer

21 nov 2025, 16:47 UTC

Charlas de Mercado

European Gas-Price Forecast to Decline Further on Expanding LNG Supply -- Market Talk

DJ

Leer

21 nov 2025, 16:35 UTC

Adquisiciones, fusiones, absorciones

What Stocks Al Gore's Investment Firm Bought and Sold This Quarter -- Barrons.com

DJ

Leer

21 nov 2025, 16:09 UTC

Ganancias

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

DJ

Leer

21 nov 2025, 15:59 UTC

Charlas de Mercado

Canadian Consumers Tapping the Brakes, Still See Resilient -- Market Talk

DJ

Leer

21 nov 2025, 15:59 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

DJ

Leer

21 nov 2025, 15:23 UTC

Charlas de Mercado

Bank of Canada Not Expected to Be Swayed by Canadian Retail Trade Data -- Market Talk

DJ

Leer

21 nov 2025, 15:17 UTC

Charlas de Mercado

Canadian Consumer Spending Softening, But Could Be Worse -- Market Talk

DJ

Leer

Comparación entre iguales

Cambio de precio

VIRIDIAN THERAPEUTICS INC previsión

Precio Objetivo

By TipRanks

34.82% repunte

Estimación a 12 Meses

Media 39.73 USD  34.82%

Máximo 61 USD

Mínimo 13.983 USD

De acuerdo con 13 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para VIRIDIAN THERAPEUTICS INC Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

13 ratings

13

Comprar

0

Mantener

0

Vender

De acuerdo con 13 analistas que ofrecen calificaciones bursátiles a para VIRIDIAN THERAPEUTICS INC Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

12 / 13.14Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Medio plazo

Bearish Evidence

All events are bearish.

Largo Plazo

Strong Bearish Evidence

All events are bearish.

Sentimiento

By Acuity

182 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Otras acciones del sector

LLY

Eli Lilly and Co.

1,058.87

↑ +1.65%

JNJ

Johnson and Johnson

203.92

↑ +0.27%

ABBV

AbbVie Inc

236.16

↑ +2.85%

UNH

UnitedHealth Group Inc

319.35

↑ +2.41%

AZN

AstraZeneca PLC ADR

91.01

↑ +2.64%
help-icon Live chat